Here we present evidence that the lncRNA LIMp27 selectively represses p27 expression and contributes to the increased proliferation, tumorigenicity, and resistance to DNA‐damaging therapeutics in p53‐mutant colon adenocarcinoma (COAD) cells. Here, CDKN1B is linked to colon adenocarcinoma.